Inspire Medical Systems (NYSE:INSP) announced today that it appointed Dr. Myriam J. Curet as an independent board director.
Curet’s appointment went into effect on Dec. 21, 2023. She currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical. Curet spoke to Medical Design & Outsourcing this year to explain the secret behind Intuitive’s surgical robotics success.
“We are excited to add Dr. Curet, a practicing, board-certified minimally invasive general surgeon with extensive business and executive leadership experience in the medical device industry to our board of directors,” said Tim Herbert, president and CEO of Inspire Medical Systems. “Dr. Curet brings significant experience in developing and commercializing scalable solutions for minimally invasive surgery and we look forward to her guidance, expertise and contributions to our board as we advance Inspire therapy to treat the many patients affected by [obstructive sleep apnea].”
In addition to her position at Intuitive, Curet serves as a professor of surgery at Stanford University. She also previously held a faculty role at the University of New Mexico. On top of her board duties at Inspire Medical, she serves on the board of another surgical robotics company, Stereotaxis. Additionally, Curet is on the board at biopharmaceutical company Nektar Therapeutics.
Minneapolis-based Inspire Medical develops minimally invasive implantable products for treating obstructive sleep apnea. It offers an alternative to the traditional CPAP machines made by the likes of Philips and ResMed. Inspire Medical’s reputation has grown over the past several years as Philips dealt with a massive CPAP recall and people moved away from that method of treatment.
The company was in the news recently for negative reasons as investors filed class action lawsuits alleging misleading statements.